OTC Discount
- Calebe de Roure,
- Emanuel Moench ,
Emanuel Moench
[email protected]https://orcid.org/0000-0001-6423-279X
Department of Finance, Frankfurt School of Finance & Management, 60322 Frankfurt, Germany; and Centre for Economic Policy Research, 75007 Paris, France
- Loriana Pelizzon ,
Corresponding Author
Loriana Pelizzon
[email protected]https://orcid.org/0000-0003-4489-0167
Centre for Economic Policy Research, 75007 Paris, France; and Leibniz Institute for Financial Research SAFE, 60323 Frankfurt, Germany; and Department of Finance, Goethe University Frankfurt, 60323 Frankfurt, Germany; and Department of Economics, Ca’ Foscari University of Venice, 30121 Venice, Italy
- Michael Schneider
Michael Schneider
[email protected]Leibniz Institute for Financial Research SAFE, 60323 Frankfurt, Germany; and Research Centre, Deutsche Bundesbank, 60325 Frankfurt, Germany
Emanuel Moench
[email protected]https://orcid.org/0000-0001-6423-279X
Department of Finance, Frankfurt School of Finance & Management, 60322 Frankfurt, Germany; and Centre for Economic Policy Research, 75007 Paris, France
Corresponding Author
Loriana Pelizzon
[email protected]https://orcid.org/0000-0003-4489-0167
Centre for Economic Policy Research, 75007 Paris, France; and Leibniz Institute for Financial Research SAFE, 60323 Frankfurt, Germany; and Department of Finance, Goethe University Frankfurt, 60323 Frankfurt, Germany; and Department of Economics, Ca’ Foscari University of Venice, 30121 Venice, Italy
Michael Schneider
[email protected]Leibniz Institute for Financial Research SAFE, 60323 Frankfurt, Germany; and Research Centre, Deutsche Bundesbank, 60325 Frankfurt, Germany
Supplemental Material
The replication files for this article are available HERE.

